SCHEMBL2300347

SCHEMBL2300347

CCN(C(=O)c1ccccc1)c1nnc(-c2ccc(C=O)cc2)s1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
S1PR1 P21453 9/20 0.53
KDM4E B2RXH2 5/20 0.53
RAB9A P51151 5/20 0.53
HSD17B10 Q99714 5/20 0.53
ALOX15 P16050 1/20 0.53
NPC1 O15118 4/20 0.52
ALDH1A1 P00352 3/20 0.52
TP53 P04637 2/20 0.52
HPGD P15428 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
NPSR1 Q6W5P4 1/20 0.52
RXFP1 Q9HBX9 1/20 0.52
MAPT P10636 1/20 0.50
CYP1A2 P05177 2/20 0.48
CYP2C9 P11712 2/20 0.48
CYP2C19 P33261 2/20 0.48
MEN1 O00255 1/20 0.48
GAA P10253 1/20 0.48
CYP2D6 P10635 1/20 0.48
KMT2A Q03164 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12386141 0.90 S1PR1 (0.68) S1PR1S1PR3
SCHEMBL2297953 0.87 KDM4E (0.55) S1PR1KDM4ERAB9AHSD17B10ALOX15
SCHEMBL2296851 0.87 S1PR1 (0.58) S1PR1KDM4ERAB9AHSD17B10ALOX15
SCHEMBL2300532 0.84 S1PR1 (0.65) S1PR1KDM4ERAB9AHSD17B10ALOX15
SCHEMBL2299676 0.84 S1PR1 (0.58) S1PR1KDM4ERAB9AHSD17B10ALOX15
SCHEMBL2297863 0.82 RAB9A (0.63) S1PR1KDM4ERAB9AHSD17B10ALOX15
SCHEMBL1488788 0.80 S1PR1 (0.65) S1PR1KDM4EHSD17B10NPC1ALDH1A1
SCHEMBL2300584 0.79 S1PR1 (0.71) S1PR1KDM4ERAB9AHSD17B10NPC1
SCHEMBL2298394 0.79 S1PR1 (0.54) S1PR1KDM4ERAB9AHSD17B10ALOX15
SCHEMBL2297303 0.78 KDM4E (0.53) S1PR1KDM4ERAB9AHSD17B10ALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110200557-A1 NEW 2-AMIDOTHIADIAZOLE DERIVATIVES ALMIRALL, S.A. (ES) 2011-08-18 US disclosed
US-20110200557-A1 NEW 2-AMIDOTHIADIAZOLE DERIVATIVES ALMIRALL, S.A. (ES) 2011-08-18 US disclosed
US-20110200557-A1 NEW 2-AMIDOTHIADIAZOLE DERIVATIVES ALMIRALL, S.A. (ES) 2011-08-18 US disclosed
WO-2010043377-A1 NEW 2-AMIDOTHIADIAZOLE DERIVATIVES ALMIRALL, S.A. (ES) 2010-04-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110200557-A1 NEW 2-AMIDOTHIADIAZOLE DERIVATIVES S1PR2, S1PR3, S1PR1 S1PR1 3/4885KDM4E 4607/4885RAB9A 3103/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.